Latest Phosphoproteomics Stories
Live webinar to focus on using quantitative phosphoproteomics to support the discovery and development of kinase-selective drugs.
Later-stage cancers thrive by finding detours around roadblocks that cancer drugs put in their path, but a Purdue University biochemist is creating maps that will help drugmakers close more routes and develop better drugs.
Changes in cell signaling proteins are induced at lower doses in female rats compared to males VANCOUVER, Aug.
When a cell divides, the genetic information in the chromosomes must be passed on error-free to the daughter cells.
Prediction of over 30 million human kinase-substrate interactions now available at PhosphoNET website VANCOUVER, BC, Feb.
Prediction of over 4.6 million human kinase-substrate interactions available in PhosphoNET website VANCOUVER, June 9 /PRNewswire/ - Kinexus Bioinformatics Corporation, a world-leader in molecular communications research, announced major advancements in its PhosphoNET KnowledgeBase (www.phosphonet.ca) for the study of cell signalling systems.
Investigators at the Burnham Institute for Medical Research (Burnham) and The Scripps Research Institute (TSRI) have made the first comparative, large-scale phosphoproteomic analysis of human embryonic stem cells (hESCs) and their differentiated derivatives.
DENVER and CAMBRIDGE, Mass., April 14 /PRNewswire/ -- (AACR 100th Annual Meeting 2009) - Genstruct Inc., a systems biology company focused on identifying molecular mechanisms, networks and biomarkers to better develop novel therapeutics, molecular diagnostics and patient-specific therapies, today announced that the results of a joint collaboration with one of its top pharmaceutical partners will be presented at the American Association for Cancer Research's (AACR) 100th Annual Meeting 2009...